Literature DB >> 24959995

Hyperglycemia enhances function and differentiation of adult rat cardiac fibroblasts.

Patricia E Shamhart1, Daniel J Luther, Ravi K Adapala, Jennifer E Bryant, Kyle A Petersen, J Gary Meszaros, Charles K Thodeti.   

Abstract

Diabetes is an independent risk factor for cardiovascular disease that can eventually cause cardiomyopathy and heart failure. Cardiac fibroblasts (CF) are the critical mediators of physiological and pathological cardiac remodeling; however, the effects of hyperglycemia on cardiac fibroblast function and differentiation is not well known. Here, we performed a comprehensive investigation on the effects of hyperglycemia on cardiac fibroblasts and show that hyperglycemia enhances cardiac fibroblast function and differentiation. We found that high glucose treatment increased collagen I, III, and VI gene expression in rat adult cardiac fibroblasts. Interestingly, hyperglycemia increased CF migration and proliferation that is augmented by collagen I and III. Surprisingly, we found that short term hyperglycemia transiently inhibited ERK1/2 activation but increased AKT phosphorylation. Finally, high glucose treatment increased spontaneous differentiation of cardiac fibroblasts to myofibroblasts with increasing passage compared with low glucose. Taken together, these findings suggest that hyperglycemia induces cardiac fibrosis by modulating collagen expression, migration, proliferation, and differentiation of cardiac fibroblasts.

Entities:  

Keywords:  cardiac fibroblast; collagen; collagène; concentration élevée de glucose; diabetes; diabète; fibroblaste cardiaque; high glucose; migration; myofibroblast; myofibroblastes; proliferation; prolifération

Mesh:

Substances:

Year:  2014        PMID: 24959995      PMCID: PMC4883005          DOI: 10.1139/cjpp-2013-0490

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  34 in total

1.  Hyperglycemia alters PI3k and Akt signaling and leads to endothelial cell proliferative dysfunction.

Authors:  Shubha Varma; Brajesh K Lal; Ruifang Zheng; Jerome W Breslin; Satoshi Saito; Peter J Pappas; Robert W Hobson; Walter N Durán
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-06-17       Impact factor: 4.733

2.  Characterization of alterations in diabetic myocardial tissue using high resolution MRI.

Authors:  Rajaprasad Loganathan; Mehmet Bilgen; Baraa Al-Hafez; Irina V Smirnova
Journal:  Int J Cardiovasc Imaging       Date:  2005-12-13       Impact factor: 2.357

3.  Absence of type VI collagen paradoxically improves cardiac function, structure, and remodeling after myocardial infarction.

Authors:  Daniel J Luther; Charles K Thodeti; Patricia E Shamhart; Ravi K Adapala; Cheryl Hodnichak; Dorothee Weihrauch; Paolo Bonaldo; William M Chilian; J Gary Meszaros
Journal:  Circ Res       Date:  2012-02-16       Impact factor: 17.367

4.  High glucose increase cell cycle regulatory proteins level of mouse embryonic stem cells via PI3-K/Akt and MAPKs signal pathways.

Authors:  Yun Hee Kim; Jung Sun Heo; Ho Jae Han
Journal:  J Cell Physiol       Date:  2006-10       Impact factor: 6.384

5.  Tranilast attenuates diastolic dysfunction and structural injury in experimental diabetic cardiomyopathy.

Authors:  Darren J Kelly; Yuan Zhang; Kim Connelly; Alison J Cox; Jennifer Martin; Henry Krum; Richard E Gilbert
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-08-24       Impact factor: 4.733

6.  Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats.

Authors:  Manuela Aragno; Raffaella Mastrocola; Giuseppe Alloatti; Ilenia Vercellinatto; Paola Bardini; Stefano Geuna; Maria Graziella Catalano; Oliviero Danni; Giuseppe Boccuzzi
Journal:  Endocrinology       Date:  2007-09-27       Impact factor: 4.736

7.  Angiotensin II type 1 receptor blocker attenuates myocardial remodeling and preserves diastolic function in diabetic heart.

Authors:  Hiroyuki Tsutsui; Shouji Matsushima; Shintaro Kinugawa; Tomomi Ide; Naoki Inoue; Yukihiro Ohta; Takashi Yokota; Sanae Hamaguchi; Kenji Sunagawa
Journal:  Hypertens Res       Date:  2007-05       Impact factor: 3.872

8.  Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts.

Authors:  Kaliyamurthi Venkatachalam; Srinivas Mummidi; Dolores M Cortez; Sumanth D Prabhu; Anthony J Valente; Bysani Chandrasekar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-02-29       Impact factor: 4.733

9.  Collagen remodelling in myocardia of patients with diabetes.

Authors:  M Shimizu; K Umeda; N Sugihara; H Yoshio; H Ino; R Takeda; Y Okada; I Nakanishi
Journal:  J Clin Pathol       Date:  1993-01       Impact factor: 3.411

10.  Aldose reductase inhibitor prevents hyperproliferation and hypertrophy of cultured rat vascular smooth muscle cells induced by high glucose.

Authors:  K Yasunari; M Kohno; H Kano; K Yokokawa; T Horio; J Yoshikawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-12       Impact factor: 8.311

View more
  17 in total

Review 1.  The Peroxisome Proliferator-Activated Receptor-Gamma Coactivator-1α-Heme Oxygenase 1 Axis, a Powerful Antioxidative Pathway with Potential to Attenuate Diabetic Cardiomyopathy.

Authors:  Maayan Waldman; Michael Arad; Nader G Abraham; Edith Hochhauser
Journal:  Antioxid Redox Signal       Date:  2020-03-25       Impact factor: 8.401

Review 2.  Unbreak my heart: targeting mitochondrial autophagy in diabetic cardiomyopathy.

Authors:  Dieter A Kubli; Åsa B Gustafsson
Journal:  Antioxid Redox Signal       Date:  2015-04-28       Impact factor: 8.401

Review 3.  Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities.

Authors:  Ilaria Russo; Nikolaos G Frangogiannis
Journal:  J Mol Cell Cardiol       Date:  2015-12-15       Impact factor: 5.000

4.  Hypoglycemic Effect of Jicama (Pachyrhizus erosus) Extract on Streptozotocin-Induced Diabetic Mice.

Authors:  Chan Joo Park; Ji-Sook Han
Journal:  Prev Nutr Food Sci       Date:  2015-06-30

5.  Parenchymal and Stromal Cells Contribute to Pro-Inflammatory Myocardial Environment at Early Stages of Diabetes: Protective Role of Resveratrol.

Authors:  Monia Savi; Leonardo Bocchi; Roberto Sala; Caterina Frati; Costanza Lagrasta; Denise Madeddu; Angela Falco; Serena Pollino; Letizia Bresciani; Michele Miragoli; Massimiliano Zaniboni; Federico Quaini; Daniele Del Rio; Donatella Stilli
Journal:  Nutrients       Date:  2016-11-16       Impact factor: 5.717

Review 6.  Extracellular Vesicles as Protagonists of Diabetic Cardiovascular Pathology.

Authors:  Dakota Gustafson; Shawn Veitch; Jason E Fish
Journal:  Front Cardiovasc Med       Date:  2017-11-09

7.  Neferine inhibits proliferation and collagen synthesis induced by high glucose in cardiac fibroblasts and reduces cardiac fibrosis in diabetic mice.

Authors:  Xue Liu; Xiuhui Song; Jianjun Lu; Xueying Chen; Ershun Liang; Xiaoqiong Liu; Mingxiang Zhang; Yun Zhang; Zhanhui Du; Yuxia Zhao
Journal:  Oncotarget       Date:  2016-09-20

8.  Rap1a Regulates Cardiac Fibroblast Contraction of 3D Diabetic Collagen Matrices by Increased Activation of the AGE/RAGE Cascade.

Authors:  Stephanie D Burr; James A Stewart
Journal:  Cells       Date:  2021-05-22       Impact factor: 6.600

Review 9.  Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities.

Authors:  Izabela Tuleta; Nikolaos G Frangogiannis
Journal:  Adv Drug Deliv Rev       Date:  2021-07-29       Impact factor: 17.873

10.  MicroRNA-9 inhibits high glucose-induced proliferation, differentiation and collagen accumulation of cardiac fibroblasts by down-regulation of TGFBR2.

Authors:  Jiaxin Li; Yingnan Dai; Zhendong Su; Guoqian Wei
Journal:  Biosci Rep       Date:  2016-11-29       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.